The largest community for pharma industry writers and readers

JOIN 2020 TPMG ONLINE PHARMA SUMMIT

CALL FOR AUTHOR - 2020 FEATURED WRITERS

REGULATORY AFFAIRS


Newsletter

REGULATORY AFFAIRS from The Pharmaceutical Marketing Group is a regular email newsletter about regulatory affairs.

Direct to your inbox

Stay up to date with the latest appointments by subscribing to REGULATORY AFFAIRS! from The Pharmaceutical Marketing Group

View the newsletter archive

FDA Grants IND Approval to Promising Anti-Cancer Agent Veyonda®

SYDNEY--(BUSINESS WIRE)--Noxopharm (ASX: NOX) announced today that the U.S....

Lysogene Receives FDA Fast Track Designation for LYS-SAF302 Gene Therapy in MPS IIIA

PARIS--(BUSINESS WIRE)--Regulatory News: Lysogene (Paris:LYS) (FR0013233475 – LYS), a...

FDA Grants Premarket Clearance of Asuragen’s AmplideX® Fragile X Dx and Carrier Screen Kit

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a molecular diagnostics company delivering...

Teva Announces FDA Approval of ArmonAir® Digihaler™ (fluticasone propionate) Inhalation Powder

TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Respiratory, LLC, an...

Cortexyme Provides Regulatory Update for COR388 Development Program in Alzheimer’s Disease

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX) today...

Orthofix Announces FDA Approval of STIM onTrack 2.1 Mobile App for Bone Growth Stimulators

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical...